ADMA生物制品 ADMA
$12.73 −$0.48 (-3.63%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $12.74 +0.08%
开盘$12.88
昨收$13.21
当日区间$12.52 – $13.20
成交量4.65M
市值$2.82B
市盈率（TTM）16.5
股息率–
财报
财报日平均波动±12.1%近16次财报
收涨次数10 / 1663% 的概率
最佳反应+30.9%
最差反应-16.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | ±11.4% | +8.64% | 符合区间 |
| 2026/Q1 | 6 May 2026 | After Market | ±14.5% | -15.97% | 超出定价预期 |
| 2025/Q4 | 25 Feb 2026 | After Market | ±11.9% | -3.19% | 符合区间 |
| 2025/Q3 | 5 Nov 2025 | After Market | ±16.1% | -8.72% | 符合区间 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±15.5% | -9.65% | 符合区间 |
| 2025/Q1 | 7 May 2025 | After Market | ±14.3% | -10.21% | 符合区间 |
| 2024/Q4 | 3 Mar 2025 | After Market | ±18.4% | +7.45% | 符合区间 |
| 2024/Q3 | 7 Nov 2024 | After Market | ±17.1% | +14.71% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | After Market | ±24.8% | +30.93% | 超出定价预期 |
| 2024/Q1 | 9 May 2024 | After Market | ±11.4% | +27.13% | 超出定价预期 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±16.2% | -0.37% | 符合区间 |
| 2023/Q3 | 8 Nov 2023 | After Market | ±33.1% | +5.80% | 符合区间 |
| 2023/Q2 | 9 Aug 2023 | After Market | ±37.7% | +6.16% | 符合区间 |
| 2023/Q1 | 10 May 2023 | After Market | ±33.6% | +10.92% | 符合区间 |
| 2022/Q4 | 23 Mar 2023 | After Market | ±27.3% | +6.75% | 符合区间 |
| 2022/Q3 | 9 Nov 2022 | After Market | ±24.3% | +27.53% | 超出定价预期 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$124.40M+2.0% YoY
营业利润$52.45M+22.5% YoY
净利润$37.82M+10.5% YoY
摊薄每股收益$0.16+14.3% YoY
自由现金流$27.28M+46.6% YoY
经营现金流$29.54M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率64.7%
营业利润率42.3%
净利率33.0%
净资产收益率41.9%
资产收益率27.2%
投入资本回报率31.7%
流动比率6.97
负债/资产比率40.3%
现金及投资$136.02M
总负债$202.66M
净现金（净负债）-$66.64M
自由现金流/营收22.7%
暂无评论——快来第一个聊聊 ADMA。